Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-07-02 00:00:00 ET · period of report 2024-07-01 · accession 0001649094-24-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-02 | 2024-07-01 | PCVX | Wassil Jim | COO | S - Sale | $76.34 | -3,000 | 212.3K | -1% | -$229.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | S | D | 111 | $77.22 | 210,503 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-01 | S | D | 1,663 | $76.71 | 210,614 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $76.21 to $77.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-07-01 | S | D | 1,226 | $75.75 | 212,277 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $75.21 to $76.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |